ESR has acquired a business park in the Shanghai biotech cluster known as Zhangjiang Pharma Valley, marking the industrial specialist’s first-ever life sciences asset.
Hong Kong-listed ESR bought the two-building campus from mainland developer Yango for an undisclosed price earlier… Read More>>